These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28410493)

  • 1. Oxadiazole-substituted naphtho[2,3-b]thiophene-4,9-diones as potent inhibitors of keratinocyte hyperproliferation. Structure-activity relationships of the tricyclic quinone skeleton and the oxadiazole substituent.
    Basoglu A; Dirkmann S; Zahedi Golpayegani N; Vortherms S; Tentrop J; Nowottnik D; Prinz H; Fröhlich R; Müller K
    Eur J Med Chem; 2017 Jul; 134():119-132. PubMed ID: 28410493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Halo-substituted naphtho[2,3-b]thiophene-4,9-diones as redox-active inhibitors of keratinocyte hyperproliferation with reduced membrane-damaging properties.
    Lindenschmidt C; Krane D; Vortherms S; Hilbig L; Prinz H; Müller K
    Eur J Med Chem; 2016 Mar; 110():280-90. PubMed ID: 26840368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular generation of superoxide.
    Reichstein A; Vortherms S; Bannwitz S; Tentrop J; Prinz H; Müller K
    J Med Chem; 2012 Aug; 55(16):7273-84. PubMed ID: 22845014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of lapacho analogues. 2. Modification of the basic naphtho[2,3-b]furan-4,9-dione, redox activation, and suppression of human keratinocyte hyperproliferation by 8-hydroxynaphtho[2,3-b]thiophene-4,9-diones.
    Bannwitz S; Krane D; Vortherms S; Kalin T; Lindenschmidt C; Zahedi Golpayegani N; Tentrop J; Prinz H; Müller K
    J Med Chem; 2014 Jul; 57(14):6226-39. PubMed ID: 24964246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.
    Kummari LK; Butler MS; Furlong E; Blundell R; Nouwens A; Silva AB; Kappler U; Fraser JA; Kobe B; Cooper MA; Robertson AAB
    Bioorg Med Chem; 2018 Nov; 26(20):5408-5419. PubMed ID: 30322754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 10-benzyl-substituted 4,5-dichloro-10H-anthracen-9-ones as inhibitors of keratinocyte hyperproliferation.
    Kratz U; Prinz H; Müller K
    Eur J Med Chem; 2010 Nov; 45(11):5278-85. PubMed ID: 20828887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.
    Muraglia E; Altamura S; Branca D; Cecchetti O; Ferrigno F; Orsale MV; Palumbi MC; Rowley M; Scarpelli R; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6083-7. PubMed ID: 18930398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of diphenylalkyloxadiazoles as novel cardiac myosin activator.
    Manickam M; Boggu PR; Pillaiyar T; Sharma N; Jalani HB; Venkateswararao E; Jung SH
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2369-2374. PubMed ID: 29937058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth.
    Putic A; Stecher L; Prinz H; Müller K
    Eur J Med Chem; 2010 Nov; 45(11):5345-52. PubMed ID: 20850910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase.
    Benmansour F; Eydoux C; Querat G; de Lamballerie X; Canard B; Alvarez K; Guillemot JC; Barral K
    Eur J Med Chem; 2016 Feb; 109():146-56. PubMed ID: 26774922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.
    Zhang HZ; Kasibhatla S; Kuemmerle J; Kemnitzer W; Ollis-Mason K; Qiu L; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
    J Med Chem; 2005 Aug; 48(16):5215-23. PubMed ID: 16078840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.
    Yang X; Liu G; Li H; Zhang Y; Song D; Li C; Wang R; Liu B; Liang W; Jing Y; Zhao G
    J Med Chem; 2010 Feb; 53(3):1015-22. PubMed ID: 20055416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
    Bondock S; Adel S; Etman HA; Badria FA
    Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability.
    Sławiński J; Szafrański K; Pogorzelska A; Żołnowska B; Kawiak A; Macur K; Belka M; Bączek T
    Eur J Med Chem; 2017 May; 132():236-248. PubMed ID: 28364658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
    Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
    Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization.
    Kamal A; Shaik AB; Polepalli S; Reddy VS; Kumar GB; Gupta S; Krishna KV; Nagabhushana A; Mishra RK; Jain N
    Org Biomol Chem; 2014 Oct; 12(40):7993-8007. PubMed ID: 25181296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole.
    Glomb T; Szymankiewicz K; Świątek P
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30567416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimicrobial activity and cytotoxicity of novel oxadiazole derivatives.
    Kaplancikli ZA; Altintop MD; Turan-Zitouni G; Ozdemir A; Ozic R; Akalin G
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):51-7. PubMed ID: 21534862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors.
    Koryakova AG; Ivanenkov YA; Ryzhova EA; Bulanova EA; Karapetian RN; Mikitas OV; Katrukha EA; Kazey VI; Okun I; Kravchenko DV; Lavrovsky YV; Korzinov OM; Ivachtchenko AV
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3661-6. PubMed ID: 18502121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3,4-oxadiazole: a privileged structure in antiviral agents.
    Li Z; Zhan P; Liu X
    Mini Rev Med Chem; 2011 Nov; 11(13):1130-42. PubMed ID: 22353222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.